These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 14668703)
41. Myocardial endothelin-1 plays a good role and an aggravating role in the failing heart in rats with chronic heart failure. Miyauchi T; Sakai S; Sugishita Y Circulation; 1997 Oct; 96(8):2746. PubMed ID: 9355930 [No Abstract] [Full Text] [Related]
42. Office and out-of-office heart rate and the development of metabolic disorders. Obara T; Ohkubo T; Imai Y Am J Hypertens; 2009 Feb; 22(2):130. PubMed ID: 19158672 [No Abstract] [Full Text] [Related]
43. Myocardial Hypoxia in Dilated Cardiomyopathy: Is it Just a Matter of Supply and Demand? Zheng J; Gropler RJ Circ Heart Fail; 2015 Nov; 8(6):1011-3. PubMed ID: 26578667 [No Abstract] [Full Text] [Related]
44. Intramyocardial inflammation in dilated cardiomyopathy--what makes a difference? Noutsias M; Pauschinger M; Schultheiss HP; Kühl U Med Sci Monit; 2002 Oct; 8(10):LE45. PubMed ID: 12434790 [No Abstract] [Full Text] [Related]
46. Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy. Greenwell AA; Gopal K; Ussher JR Front Physiol; 2020; 11():570421. PubMed ID: 33041869 [TBL] [Abstract][Full Text] [Related]
47. Overview: what is insulin resistance? Kelley DE Nutr Rev; 2000 Mar; 58(3 Pt 2):S2-3. PubMed ID: 10812925 [No Abstract] [Full Text] [Related]
48. [Dysplastic cardiomyopathy and its relationship with cardiac development]. Song LF Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):289-90. PubMed ID: 19100000 [No Abstract] [Full Text] [Related]
49. [Dilated cardiomyopathy: present views of its etiology and pathogenesis]. Gurevich MA; Grigor'eva NM Klin Med (Mosk); 2001; 79(5):4-7. PubMed ID: 11510185 [No Abstract] [Full Text] [Related]
50. Desmin cytoskeleton in healthy and failing heart. Capetanaki Y Heart Fail Rev; 2000 Oct; 5(3):203-20. PubMed ID: 16228905 [No Abstract] [Full Text] [Related]
51. Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics. Mak D; Ryan KA; Han JC Front Pediatr; 2021; 9():756593. PubMed ID: 34778146 [TBL] [Abstract][Full Text] [Related]
52. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Paton JF; Sobotka PA; Fudim M; Engelman ZJ; Hart EC; McBryde FD; Abdala AP; Marina N; Gourine AV; Lobo M; Patel N; Burchell A; Ratcliffe L; Nightingale A Hypertension; 2013 Jan; 61(1):5-13. PubMed ID: 23172927 [No Abstract] [Full Text] [Related]
54. Reply: Risk Stratification in Dilated Cardiomyopathy: Is the Arrhythmogenic Substrate Stable Over Time? Di Marco A; Schmitt M; Anguera I JACC Heart Fail; 2017 May; 5(5):394-395. PubMed ID: 28449802 [No Abstract] [Full Text] [Related]
55. [Is glucosis only basic energy substrate?]. Sobotka L Vnitr Lek; 2016; 62(11 Suppl 4):S100-102. PubMed ID: 27921433 [TBL] [Abstract][Full Text] [Related]
56. Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery. Ponzoni M; Coles JG; Maynes JT Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834573 [TBL] [Abstract][Full Text] [Related]
57. Activation of an accessory pathway of glucose metabolism to treat dilated cardiomyopathy. Eschenhagen T Eur Heart J; 2022 Sep; 43(36):3490-3492. PubMed ID: 35923092 [No Abstract] [Full Text] [Related]
58. Augmenting outcomes in advanced heart failure: a lot to learn. Starling RC Eur J Heart Fail; 2016 Mar; 18(3):326-7. PubMed ID: 26821768 [No Abstract] [Full Text] [Related]
59. Gender medicine in dilated cardiomyopathy: pride and prejudice. Sinagra G; Merlo M; Cannatà A Eur J Heart Fail; 2018 Oct; 20(10):1401-1403. PubMed ID: 30091491 [No Abstract] [Full Text] [Related]